| The department shall enter into a drug rebate agreement with |
each manufacturer of prescription drugs under the Medicaid |
program in accordance with Section 1927 of the federal Social |
Security Act, as long as the agreements are consistent with state |
and federal law, are approved by the federal Health Care Finance |
Administration and result in a net increase in rebate revenue |
available to the Maine Medicaid Program. Individual rebate |
agreements may vary. The department shall seek to achieve an |
aggregate rebate amount from all agreements that is at least 6 |
percentage points higher than the percentage of the total |
Medicaid drug expenditures that the rebates would otherwise be |
under Section 1927 of the federal Social Security Act. Any |
increase in revenue from the Medicaid drug rebate program over |
accepted estimates as of the effective date of this section that |
results in a higher percentage of the total Medicaid drug rebates |
must be reserved to provide coverage pursuant to section 3174-G, |
subsection 1-A 1-C. In the event that the department is not |
able to achieve the rebate amount required by this section |
without compromising the best interest of Medicaid recipients and |
the Medicaid drug rebate program, the department shall report to |
the joint standing committee of the Legislature having |
jurisdiction over health and human services matters and the joint |
standing committee of the Legislature having jurisdiction over |
appropriations and financial affairs in the next regular session |
of the 119th Legislature. |